Stay updated on CAR T vs. PD-1 KO for NSCLC Clinical Trial
Sign up to get notified when there's something new on the CAR T vs. PD-1 KO for NSCLC Clinical Trial page.

Latest updates to the CAR T vs. PD-1 KO for NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical study involving anti-MUC1 CAR T cells and PD-1 knockout engineered T cells for lung cancer patients, while adding references to a new revision and other terms related to the study.SummaryDifference22%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to CAR T vs. PD-1 KO for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR T vs. PD-1 KO for NSCLC Clinical Trial page.